Align Technology, Inc. ALGN

FY2025 · ended Dec 31, 2025 · Revenue $4.03B, +0.9% YoY · Filed Feb 27, 2026

Align Technology, Inc. (ALGN) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $4.0 billion and net income of $410.4 million. Free cash flow was $490.8 million. As of Sep 30, 2026 it held $1.1 billion in cash and investments and $146.5 million in total debt.

Revenue (TTM)
$4.16B
+4.4% vs year-ago TTM
Net income (TTM)
$491.87M
+30.0% vs year-ago TTM
Operating cash flow (TTM)
$749.89M
+14.3% vs year-ago TTM
Free cash flow (TTM)
$602.50M
+6.3% vs year-ago TTM
EPS (TTM)
$6.88
+33.2% vs year-ago TTM
Dividend per share
None
Shares outstanding
71.28M
-3.1% vs prior year
Net cash
$998.47M
as of Sep 30, 2026
Operating margin
14.9%
FY 2026

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
ALGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Tempe, AZ
SEC filer status
Large accelerated filer
SEC CIK
1097149

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$4.0B
$4.0B
$3.9B
$3.7B
$4.0B
Operating income
$545.8M
$607.6M
$643.3M
$642.6M
$976.4M
Net income
$410.4M
$421.4M
$445.1M
$361.6M
$772.0M
Diluted EPS
$5.65
$5.62
$5.81
$4.61
$9.69
Operating cash flow
$593.2M
$738.2M
$785.8M
$568.7M
$1.2B
Free cash flow
$490.8M
$622.7M
$608.1M
$276.8M
$771.4M
Total assets
$6.2B
$6.2B
$6.1B
$5.9B
$5.9B
Total liabilities
$2.2B
$2.4B
$2.5B
$2.3B
$2.3B
Stockholders' equity
$4.0B
$3.9B
$3.6B
$3.6B
$3.6B
Cash and investments
$1.1B
$1.0B
$980.8M
$1.0B
$1.3B
Total debt
$114.4M
$119.3M
$126.6M
$126.9M
$125.4M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 28, 2026 Oct 26, 2026
8-K Current report
Results of operations
Oct 28, 2026 Oct 28, 2026
8-K Current report
Officer or director change
Aug 31, 2026 Aug 27, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Jul 29, 2026 Jul 29, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.